Tag:
DAR-311
Latest Headlines
Latest Headlines
Gilead touts Phase III hypertension drug
Gilead Sciences says that its treatment for resistant high blood pressure met the primary endpoint in the first of two Phase III studies. More than half of the patients treated with darusentan
